Adverse Events with Concurrent Cannabis Use During Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder: A Case Series Analysis

Affiliations

• ¹ Butler Hospital TMS/Neuromodulation Research Facility, 345 Blackstone Blvd., Providence, RI, USA, 02906.
• ² Butler Hospital TMS/Neuromodulation Research Facility, 345 Blackstone Blvd., Providence, RI, USA, 02906; New York Medical College, School of Medicine, 40 Sunshine Cottage Rd., Valhalla, NY, USA, 10595.
• ³ Psychiatric Neurotherapeutics Program, Division of Depression and Anxiety Disorder, McLean Hospital, 115 Mill St., Belmont, MA, USA, 02478; Department of Psychiatry, Harvard Medical School, 25 Shattuck St., Boston, MA, USA, 02115.
• ⁴ Psychiatric Neurotherapeutics Program, Division of Depression and Anxiety Disorder, McLean Hospital, 115 Mill St., Belmont, MA, USA, 02478; Department of Psychiatry, Harvard Medical School, 25 Shattuck St., Boston, MA, USA, 02115; Southern California Permanente Medical Group, 393 E Walnut St., Pasadena, CA, USA, 91188.
• ⁵ Butler Hospital TMS/Neuromodulation Research Facility, 345 Blackstone Blvd., Providence, RI, USA, 02906; Department of Psychiatry and Human Behavior, Brown University Warren Alpert Medical School at Brown University, 222 Richmond St., Providence, RI, USA, 02903. Electronic address: Linda_Carpenter_MD@brown.edu.